Health News Releases

  • Today May 22
December 04, 2014 23:30
St. Luke’s Medical Center-Global City Trusts UpToDate to Support Exceptional Standards of Care
Wolters Kluwer Health (http://goo.gl/o2rWK), a leading global provider of information for healthcare professionals and students, announced today that St. Luke’s Medical Center-Global City is among the
December 02, 2014 16:40
Quintiles Launches Marketed Product Maintenance Offering to Better Manage Established Products
Quintiles today announced a new offering that combines its industry-leading pharmacovigilance, regulatory dossier/label maintenance, benefit-risk management, and analytic expertise into one integrated
December 02, 2014 15:50
Takeda’s Investigational, Oral Proteasome Inhibitor Ixazomib Granted Breakthrough Therapy Designation by U.S. FDA for Relapsed or Refractory Systemic Light-chain Amyloidosis
Takeda Pharmaceutical Company Limited (TSE:4502) today announced that the U.S. Food & Drug Administration (FDA) has granted Breakthrough Therapy status to the company’s investigational, oral proteasom
December 01, 2014 16:30
AHF Global World AIDS Day Events Focus On Testing and Treatment
PHOTO: For World AIDS Day, AHF will host over 160 events around the world to promote testing, treatment for HIV/AIDS; international commemorations will launch global campaign to connect twenty million
November 28, 2014 23:00
PENTAX Medical Launches New ENT Videoscope Solution
PENTAX Medical launches today the new VIVIDEO system, an advanced ENT videoscope solution, in the European, Middle Eastern and African (EMEA) Markets. This endoscopy system consists of a video process
November 27, 2014 17:50
Vargatef® (nintedanib*) approved in the EU for lung cancer patients with advanced adenocarcinoma after first-line chemotherapy
For media outside UK, US and Canada only Today Boehringer Ingelheim announced that the European Commission has granted EU marketing authorisation for Vargatef® (nintedanib*), valid for the 28 count
November 24, 2014 16:10
Nintedanib* receives positive CHMP opinion in European Union for the treatment of IPF
For media outside UK, US and Canada Boehringer Ingelheim today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive
November 24, 2014 15:10
Cell Signaling Technology Wins “Best Antibodies” and “Most Useful Website” at The Life Science Industry Awards
Cell Signaling Technology, a leading provider of antibodies, kits and services, announced today that it has won two Life Science Industry Awards® for “Best Antibodies” and “Most Useful Website.” Hoste
November 20, 2014 17:50
Panasonic Showcases Advanced Hospital Solutions at HOSPEX Japan 2014
Panasonic exhibited a variety of advanced equipment and solutions for medical and welfare facilities at the 39th International Healthcare Engineering Exhibition (HOSPEX Japan 2014) held on November 12
November 20, 2014 13:05
Terumo BCT and Banco de Sangre de Servicios Mutuos Unite in a Treatment Use Program Developed to Help Improve Blood Supply Safety Using an Investigational Device
Due to public health concerns over the transmission of chikungunya virus (CHIKV) and dengue fever, Terumo BCT will file a submission to the U.S. Food and Drug Administration (FDA) for expanded access
November 20, 2014 13:00
ADDING MULTIMEDIA Quintiles Named a Best Workplace in South Korea
Quintiles (www.quintiles.com) announced today that it has been recognized as one of South Korea’s Best Workplaces by the Great Place to Work® Institute. This is Quintiles Korea’s first time to receive
November 19, 2014 18:45
New data show dabigatran-specific antidote idarucizumab* restores blood clotting mechanism in humans
For Non-US/Non-UK/Non-Canadian Media New data on the investigational antidote idarucizumab show that it can reverse the effect of the oral anticoagulant Pradaxa® (dabigatran etexilate) on both bloo
November 19, 2014 18:40
Two new, large scale real-world analyses show fewer major bleeds and strokes with Pradaxa® than with warfarin
For Non-US/Non-UK/Non-Canadian Media Two new real-world data analyses presented at the American Heart Association’s Scientific Sessions 2014 independently demonstrate that routine treatment with Pr
November 19, 2014 13:40
Oral OTEZLA® (Apremilast) Showed Sustained Clinical Response over Two Years in Patients with Active Psoriatic Arthritis
Celgene Corporation (NASDAQ:CELG), today announced that results from long-term (104-week) efficacy and safety analyses of OTEZLA® (apremilast) from the open-label phase of two PALACE phase III clinica
November 18, 2014 13:40
Sierra Leone Action Receives Donation of Transfusion Medicine Equipment from Fresenius Kabi
Sierra Leone Action, an organization comprising a global team of Sierra Leonean physicians and other professionals, today announced that Fresenius Kabi has donated nine Fenwal Autopheresis-C® instrume
November 18, 2014 11:35
Merck Announces Global Strategic Alliance with Pfizer on Anti-PD-L1 to Accelerate Presence in Immuno-Oncology
Merck (MRK GY) (FWB:MRK) announced today that it has entered into a global agreement with Pfizer Inc. (NYSE:PFE) to co-develop and co-commercialize MSB0010718C, an investigational anti-PD-L1 antibody
November 14, 2014 16:45
Catalent Acquires Micron Technologies
Catalent, Inc. (NYSE:CTLT), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that it has acqui
November 13, 2014 22:00
Global Survey Finds That Pancreatic Cancer, a Leading Cause of Cancer Deaths, is Virtually Unknown by Many in Europe and US
While it may not be surprising that breast and lung cancers are top of mind when people hear the word “cancer,” 60% of respondents to a recent six-country survey about cancer awareness know almost not
November 11, 2014 14:00
Thomas Casey Named Executive Vice President, Chief Financial Officer for Acelity
Acelity L.P. Inc. announced today the appointment of Thomas Casey, a well-respected financial leader, as Executive Vice President and Chief Financial Officer. Tom brings to Acelity 30 years of fina
November 10, 2014 13:05
Takeda Announces Abstracts for ADCETRIS® (brentuximab vedotin) in Hodgkin Lymphoma, Systemic Anaplastic Large Cell Lymphoma and Ixazomib in Multiple Myeloma to be Presented at 56th American Society of Hematology Annual Meeting
Takeda Pharmaceutical Company Limited (TSE:4502) today announced that abstracts of interest from studies on VELCADE® (bortezomib), ADCETRIS® (brentuximab vedotin) and the investigational oral proteaso
November 10, 2014 11:15
Avedro Granted Korean Approval for its KXL® Cross-Linking System for Lasik Xtra®
Avedro Inc., a Boston-based ophthalmic medical device and pharmaceutical company announces today that it has been granted approval from the South Korean Ministry of Food and Drug Safety (MFDS, formerl
November 07, 2014 19:50
New subgroup analysis shows Asian non-small cell lung cancer patients with most common EGFR mutation (del19) lived significantly longer with first-line GIOTRIF® (afatinib*) compared to chemotherapy
For Media In Asian Countries Only For Whom The Data Is Relevant (For media outside UK, US and Canada only) Boehringer Ingelheim today announced data from a pre-specified subgroup-analysis of the pi
November 06, 2014 10:00
GVK BIO Signs Definitive Agreement to Acquire Vanta Bioscience
Asia’s leading Discovery Research and Development organization, GVK BIO, announced the signing of a definitive agreement to acquire Vanta Bioscience, a full service preclinical GLP toxicology and safe
November 04, 2014 22:00
KineMed Receives Grant to Apply Novel Method for Measuring Muscle Mass in Infants and Children for the Diagnosis and Prevention of Malnutrition and Growth Stunting
KineMed, Inc. (www.kinemed.com) announced today that it has been awarded a three-year grant by the Bill & Melinda Gates Foundation to apply its novel, proprietary non-invasive measurement of skeletal
November 04, 2014 10:35
FDA Medicare study in 134,000 atrial fibrillation patients confirms positive safety profile and effectiveness of Pradaxa® in general practice
Non US, Non UK, Non Canadian Media On October 30, 2014, the U.S. Food and Drug Administration (FDA) Medicare analysis of 134,000 atrial fibrillation (AF) patients treated with either Pradaxa® (dabi
25 per page50 per page75 per page100 per page